 |
 |
|
2008 |
 |
- Foray into Healthcare Delivery –collaboration to
set-up 220 bed multi super-specialty hospital in NCR
- WHO prequalification for fully liquid innovative
combination Pentavalent vaccine, EasyFive* against five
deadly infectious diseases (DTwP+ Hep B+ Hib) of early
childhood.
- Granted a patent from US Patent & Trademark Office
for our product Thank GodTM (Euphorbia Prostrata) for
effective management of hemorrhoids & piles (Patent No.
7,371,412 B2)
|
|
2007 |
|
- Vaccine Formulation Plant at Baddi
- Research Agreement with Punjab University to develop New Chemical Entities for Psychiatric Disorders
|
|
2006 |
|
- WHO cGMP complaint ultra modern Pharmaceuticals
formulation facility at Baddi, Himachal Pradesh.
- Landmark collaborations with The Netherlands Vaccine
Institute (The Nederlands Vaccin Instituut (NVI)) for manufacture & marketing of finished
Inactivated Polio Vaccine (IPV) and a number of IPV
based combination vaccines in India and across the
globe.
- Collaboration with PT.Bio Farma to manufacture &
market Measles Vaccine.
- Inauguration of Biopharmaceutical R&D Centre at New
Delhi
- Pre-Qualification Certification from WHO for Supply
of Recombinant Hepatitis-B Vaccine to UN Agencies.
- Collaboration with National Research Development
Corporation (NRDC) for technology transfer of Foot and
Mouth Vaccine.
|
2005 |
In-licensing agreement with National Institute of Health, USA for Hair Growth Hormone
|
2004 |
Collaboration with Cambridge Bio-stability, UK, for Thermo Stable Vaccines
|
2004 |
Marketing Joint Venture with Chiron (now Novartis) Vaccines, UK
|
2004 |
In-licensing agreement with National Institute of Immunology, New Delhi, for Japanese Encephalitis Candidate Vaccine
|
2002 |
Commissioning of Recombinant Vaccine Production Plant
|
2002 |
In-licensing Agreement with Biotechnology Consortium of India for Development & Commercialization of Anthrax Vaccine
|
2001 |
R&D tie up with European MNC
|
1997 |
First Product Patent in Several Countries
|
1995 |
State -of the- art Drug Delivery R&D centre at Lalru
|
1995 |
IPO of Equity Shares of Rs.180 Million
|
1993 |
Merger of Panacea Drugs (P) Ltd. & Radicura Pharma to form Panacea Biotec Ltd.
|
1989 |
Pharmaceutical formulations plant at New Delhi,under the name of Panacea Drug P Ltd.
|
1988 |
Established a plant for vaccines production at New Delhi, under the name of Radicura Pharma
|
1984 |
Panacea Drug (P) Ltd. was formed |
